Krsnaa Diagnostics' Q2 FY 2025-26 Quarterly Results

Result Summary

• Krsnaa Diagnostics Ltd reported a 6.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.1%.
• Its expenses for the quarter were up by 5.4% QoQ and 7.9% YoY.
• The net profit increased 16.7% QoQ and increased 22.1% YoY.
• The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 7.25 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Krsnaa Diagnostics Ltd is a company operating within the healthcare sector, specifically focusing on diagnostic services. The company provides a variety of diagnostic services, including imaging, pathology, and radiology, catering to hospitals, clinics, and individual healthcare providers. Krsnaa Diagnostics has established a robust network of diagnostic centers across diverse geographic regions, enhancing accessibility to healthcare services. Recent developments in the industry or the company are not specified in the provided data, and thus, no additional major developments can be highlighted in this report.

Revenue

In Q2FY26, Krsnaa Diagnostics Ltd reported a total income of ₹210.16 crores. This represents a 6.7% increase on a quarter-over-quarter (QoQ) basis from Q1FY26, where the total income was ₹196.93 crores. Compared to the same quarter in the previous fiscal year, Q2FY25, the total income increased by 10.1% from ₹190.93 crores. This increase in revenue can be attributed to the company's efforts in expanding its diagnostic service offerings and enhancing its market reach.

Profitability

The profitability of Krsnaa Diagnostics Ltd showed a positive trajectory in Q2FY26. The company reported a profit before tax of ₹31.55 crores, which is a 15.1% increase from Q1FY26's profit before tax of ₹27.41 crores. Year-over-year, this metric improved by 24.2% from Q2FY25's profit before tax of ₹25.40 crores. The tax expense for Q2FY26 was ₹7.62 crores, reflecting a 10.4% QoQ increase and a 31.2% YoY rise. Consequently, the profit after tax for Q2FY26 stood at ₹23.94 crores, up by 16.7% QoQ and 22.1% YoY. This upward trend in profitability indicates that the company has effectively managed its operational costs while increasing its revenue.

Operating Metrics

Operating metrics for Krsnaa Diagnostics Ltd highlight its efficiency and performance. Total expenses for Q2FY26 amounted to ₹178.62 crores, marking a 5.4% increase from Q1FY26's expenses of ₹169.51 crores, and a 7.9% rise YoY from Q2FY25's ₹165.53 crores. The earnings per share (EPS) for Q2FY26 was ₹7.25, which is a 16.0% increase from the previous quarter's EPS of ₹6.25, and a 22.5% increase from the same quarter last year when the EPS was ₹5.92. These metrics demonstrate the company's effective cost management and its ability to enhance shareholder value through improved earnings performance.